Abstract
We have investigated the requirement for mitogen-activated protein (MAP) kinase in the stimulation of DNA synthesis by platelet-derived growth factor (PDGF) in rat aortic smooth muscle cells using a phosphorothioate-modified oligodeoxy-nucleotide (ODN) to deplete MAP kinase. Treatment for 72 h with MAP kinase antisense ODN directed against both the p42 and p44 isoforms of MAP kinase abolished the expression of MAP kinase and reduced agonist-stimulated MAP kinase activity by approx. 95%. The scrambled control ODN was without effect, but the sense control ODN slightly enhanced the expression of both isoforms. Abolition of MAP kinase activity by antisense ODN treatment prevented angiotensin II- and PDGF-stimulated activation of p90 ribosomal S6 kinase activity, but did not affect activation of MAP kinase kinase. In addition, antisense ODN pretreatment reduced PDGF-stimulated [3H]thymidine incorporation to < 5% of control, and decreased basal incorporation by approx. 90%. In contrast, basal [3H]thymidine incorporation was enhanced approx. 60% by control sense ODN treatment. These results indicate an obligatory role for MAP kinase in the activation of a number of early events in mitogenesis, including DNA synthesis, in vascular smoo...Continue Reading
Citations
Jan 28, 1998·Molecular Pharmacology·C SchumacherL Wennogle
Sep 8, 1998·The American Journal of Physiology·S S El-DahrW H Baricos
Apr 6, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·J H LeeJ L Black
Apr 24, 2003·The Journal of Biological Chemistry·Christopher CalabreseRichard Gilbertson
Dec 9, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sabine C WolfBernhard R Brehm
Apr 7, 1997·FEBS Letters·C H ArnottG J Sale
Jul 31, 2013·FEBS Letters·Tyler C Moore, Thomas M Petro
Jul 2, 1999·International Journal of Cancer. Journal International Du Cancer·K B ReddyC A Diglio
Jan 15, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·X P XiR E Law
Apr 3, 1999·The Journal of Biological Chemistry·M Z HossainA L Boynton
Feb 4, 1999·Hypertension·S GoetzeR E Law
May 18, 1999·The American Journal of Physiology·H Y LinP J Davis
Nov 5, 1999·Journal of Biomedical Science·S P WuP W Gean
Jul 11, 2006·Molecular Biology of the Cell·Yoo-Jeong HanPrimal de Lanerolle
Dec 31, 1997·FEBS Letters·X P XiR E Law
May 29, 2002·Cardiovascular Research·Bo LiuPeter Groves
Apr 1, 1999·FEBS Letters·E M SaleG J Sale
Oct 27, 2004·Nature Immunology·Fuan WangGrant McFadden
Mar 16, 2000·Experimental Neurology·M Bani-YaghoubC C Naus
Mar 21, 2001·Cellular Signalling·C J RobinsonR Plevin
Oct 1, 1998·Cellular Signalling·S M LairdR Plevin
Mar 21, 1998·Cellular Signalling·M G Thompson, R M Palmer
Jun 8, 2001·Atherosclerosis·M FisherP H Groves
Jan 27, 1999·Atherosclerosis·F NiculescuH Rus
Sep 5, 2001·Kidney International·K Y HungB S Hsieh